Alcon AG | ALC - Current Assets



Alcon AG reported $6.31B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AstraZeneca USD 28.94B 2.8B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Essilor EUR 11.03B 991M Jun/2025
Fresenius EUR 10.88B 1.03B Jun/2025
Fresenius Medical Care EUR 8.14B 178.09M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.2B 216M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Philips EUR 9.06B 394M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
Smith & Nephew USD 4.63B 206M Jun/2025
Sonova Holding CHF 1.44B 207.4M Sep/2024
UCB EUR 4.79B 1.47B Dec/2024